Biofrontera Ag ADR (BFRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BFRA | AZN | AMGN | GILD | VRTX |
| Company | Biofrontera Ag ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.10 | 90.43 | 325.56 | 121.19 | 446.86 |
| High | 3.10 | 91.87 | 330.76 | 126.27 | 456.12 |
| Low | 2.60 | 90.36 | 324.73 | 121.00 | 445.51 |
| Latest | 2.67 | 91.35 | 327.25 | 124.23 | 456.20 |
| Change | -0.28 | +0.74 | +2.83 | +2.76 | +8.82 |
| % Change | -9.49% | +0.82% | +0.87% | +2.27% | +1.97% |
| Volume | 4,900 | 4,740,851 | 2,638,585 | 9,058,277 | 1,279,416 |
| 20-Day Average Volume | 28,690 | 5,796,846 | 2,844,770 | 6,988,503 | 1,379,099 |
| Previous Close | 2.95 | 90.61 | 324.42 | 121.47 | 447.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.98 | 91.07 | 330.52 | 123.05 | 443.09 |
| 20-Day Raw Stochastic | 36.45% | 50.26% | 45.85% | 63.84% | 70.55% |
| 20-Day Relative Strength | 43.80 | 58.38 | 53.77 | 54.75 | 57.79 |
| Weighted Alpha | -61.60 | +42.98 | +24.86 | +32.83 | +12.58 |
| Today's Opinion | 96% Sell | 100% Buy | 72% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 96% Sell | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.87% since 02/25/22 | +2.04% since 12/12/25 | +3.22% since 12/12/25 | +3.49% since 12/12/25 | -0.12% since 12/12/25 |
| Low | 2.58 on 03/02/22 | 89.85 on 12/17/25 | 319.06 on 12/15/25 | 118.17 on 12/16/25 | 445.41 on 12/18/25 |
| High | 3.30 on 02/28/22 | 91.87 on 12/19/25 | 330.76 on 12/19/25 | 126.27 on 12/19/25 | 459.05 on 12/16/25 |
| 1-Month | |||||
| %Chg | -6.43% since 02/04/22 | +3.00% since 11/19/25 | -4.21% since 11/19/25 | -2.71% since 11/19/25 | +7.23% since 11/19/25 |
| Low | 2.09 on 02/14/22 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 420.00 on 11/20/25 |
| High | 3.68 on 02/09/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -21.47% since 12/03/21 | +20.16% since 09/19/25 | +14.91% since 09/19/25 | +9.22% since 09/19/25 | +17.84% since 09/19/25 |
| Low | 2.09 on 02/14/22 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 3.99 on 12/21/21 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -54.82% since 09/03/21 | +29.54% since 06/18/25 | +13.24% since 06/18/25 | +15.38% since 06/18/25 | +0.69% since 06/18/25 |
| Low | 2.09 on 02/14/22 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 6.89 on 10/22/21 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 75,719 | 281,020,224 | 174,694,016 | 150,705,408 | 113,508,800 |
| Shares Outstanding, K | 28,359 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 34,660,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -14,880,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 6,340,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -6,840,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.02 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 04/11/22 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.66 | 14.91 | 14.82 | 29.36 |